[1] |
Poirier P, Cornier MA, Mazzone T, et al. Bariatric surgery and cardiovascular risk factors: a scientific statement from the American Heart Association [J]. Circulation, 2011, 123(15): 1683-1701.
|
[2] |
Rodriguez FM, Aguilar SC, Piché ME, et al. Effect of bariatric surgery on heart failure [J]. Expert review of cardiovascular therapy, 2017, 15(8): 567-579.
|
[3] |
Petta S, Argano C, Colomba D, et al. Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: association with the severity of liver disease [J]. Journal of hepatology, 2015, 62(4): 928-933.
|
[4] |
Simon TG, Bamira DG, Chung RT, et al. Nonalcoholic steatohepatitis is associated with cardiac remodeling and dysfunction [J]. Obesity (Silver Spring), 2017, 25(8): 1313-1316
|
[5] |
Goyal BR, Mehta AA. Diabetic cardiomyopathy: pathophysiological mechanisms and cardiac dysfuntion [J]. Hum Exp Toxicol, 2013, 32(6): 571-590.
|
[6] |
Lee WS, Kim J. Diabetic cardiomyopathy: where we are and where we are going [J]. The Korean journal of internal medicine, 2017, 32(3): 404-421.
|
[7] |
Mulloy A, Siouti L, Beauchesne L, et al. Clinical implications of left atrial size adjustment: Impact of obesity [J]. Arch Cardiovasc Dis, 2021, 114(8-9): 561-569.
|
[8] |
Miki T, Yuda S, Kouzu H,et al. Diabetic cardiomyopathy: pathophysiology and clinical features [J]. Heart failure reviews, 2013, 18(2): 149-166.
|
[9] |
Packer M. Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium [J]. Journal of the American College of Cardiology, 2018, 71(20): 2360-2372.
|
[10] |
Ren J, Wu NN, Wang S, et al. Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications [J]. Physiol Rev, 2021, 101(4): 1745-1807.
|
[11] |
Owan T, Avelar E, Morley K, et al. Favorable changes in cardiac geometry and function following gastric bypass surgery: 2-year follow-up in the Utah obesity study [J]. Journal of the American College of Cardiology, 2011, 57(6): 732-739.
|
[12] |
Fayad ZA, Swirski FK, Calcagno C, et al. Monocyte and macrophage dynamics in the cardiovascular system: JACC Macrophage in CVD Series (Part 3) [J]. Journal of the American College of Cardiology, 2018, 72(18): 2198-2212.
|
[13] |
Kaczorowski DJ, Nakao A, McCurry KR, et al. Toll-like receptors and myocardial ischemia/reperfusion, inflammation, and injury [J]. Current cardiology reviews, 2009, 5(3): 196-202.
|
[14] |
Spirig R, Tsui J, Shaw S. The emerging role of TLR and innate immunity in cardiovascular disease [J]. Cardiology research and practice, 2012, 2012: 181394.
|
[15] |
Kapelouzou A, Katsimpoulas M, Kontogiannis C, et al. A high-cholesterol diet increases toll-like receptors and other harmful factors in the rabbit myocardium: The beneficial effect of statins [J]. Current issues in molecular biology, 2021, 43(2): 818-830.
|
[16] |
Kapelouzou A, Giaglis S, Peroulis M, et al. Overexpression of Toll-Like receptors 2, 3, 4, and 8 is correlated to the vascular atherosclerotic process in the hyperlipidemic rabbit model: The effect of statin treatment [J]. Journal of vascular research, 2017, 54(3): 156-169.
|
[17] |
Salagianni M, Galani IE, Lundberg AM, et al. Toll-like receptor 7 protects from atherosclerosis by constraining "inflammatory" macrophage activation [J]. Circulation, 2012, 126(8): 952-962.
|
[18] |
Aggarwal R, Harling L, Efthimiou E, et al. The effects of bariatric surgery on cardiac structure and function: A systematic review of cardiac imaging outcomes [J]. Obesity surgery, 2016, 26(5): 1030-1040.
|
[19] |
Piché ME, Clavel MA, Auclair A, et al. Early benefits of bariatric surgery on subclinical cardiac function: Contribution of visceral fat mobilization [J]. Metabolism: clinical and experimental, 2021, 119: 154773.
|
[20] |
Mozaffarian D, Lemaitre RN, King IB, et al. Circulating long-chain ω-3 fatty acids and incidence of congestive heart failure in older adults: the cardiovascular health study: a cohort study [J]. Annals of internal medicine, 2011, 155(3): 160-170.
|
[21] |
Mozaffarian D, Wu JH. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events [J]. Journal of the American College of Cardiology, 2011, 58(20): 2047-2067.
|